These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6081168)

  • 21. [Surgical treatment of progressive lung cancer].
    Suzuki C; Hashimoto K
    Shujutsu; 1967 Sep; 21(9):857-61. PubMed ID: 5592175
    [No Abstract]   [Full Text] [Related]  

  • 22. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
    Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
    Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer].
    Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM
    Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
    Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
    Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in peripheral blood composition following single and repeated courses of intermittent cancer chemotherapy.
    Wiktor-Jedrzejczak W; Siekierzynski M; Rychowiecka E; Bukowska B; Czarnecki C
    Med Interne; 1982; 20(4):289-94. PubMed ID: 6985497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EST 0469B--comparison of high- and low-dose cyclophosphamide in human lung cancer.
    Hall TC; Pocock S; Brodovsky H; Horton J; Shnider BI; Colsky J; Oberfield RA
    Med Pediatr Oncol; 1978; 5(1):231-40. PubMed ID: 370535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
    Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
    [No Abstract]   [Full Text] [Related]  

  • 29. [Polychemotherapy of small-cell lung cancer].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
    Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Takahashi K; Sasaki Y; Seki S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A pilot study of combination chemotherapy with cyclophosphamide, adriamycin, chronic daily dosing of oral etoposide for patients with SCLC ineligible for intensive chemotherapy].
    Fujita A; Takabatake H; Tagaki S; Sekine K
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):389-93. PubMed ID: 7880110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of primary cancer of the lung by means of cyclophosphamide].
    Lauria D; Liotti G; Tucci M
    Clin Ter; 1965 Sep; 34(5):415-27. PubMed ID: 5851918
    [No Abstract]   [Full Text] [Related]  

  • 34. Small cell carcinoma of the lung: rapid development of acute leukemia.
    Jackson DV; Cruz JM; Woodruff R
    N C Med J; 1983 Aug; 44(8):475-6. PubMed ID: 6314156
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
    Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
    Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of Scutellaria baicalensis extract on the immunologic status of patients with lung cancer receiving antineoplastic chemotherapy].
    Smol'ianinov ES; Gol'dberg VE; Matiash MG; Ryzhakov VM; Boldyshev DA; Litvinenko VI; Dygaĭ AM
    Eksp Klin Farmakol; 1997; 60(6):49-51. PubMed ID: 9460600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.